Literature DB >> 10589043

Increased peripheral blood gamma delta T-cells in patients with lymphoid neoplasia: A diagnostic dilemma in flow cytometry.

J McClanahan1, P I Fukushima, M Stetler-Stevenson.   

Abstract

We have observed increased numbers of non-neoplastic gammadelta-T-cells in the peripheral blood of a series of patients with non-Hodgkin's lymphoma not of gammadelta-T-cell origin. The majority of normal gammadelta-T-cells are negative for surface CD4 and CD8 and a subpopulation does not express CD5, two immunophenotypic findings strongly suggestive of neoplasia in alpha beta T-cells. In addition, they express cytotoxic T-cell/Natural killer cell antigens. In this study, up to 22% of PBLs were CD4 and CD8 negative gammadelta-T-cells and up to 33% PBLs were CD5 negative gammadelta-T-cells. In addition, as high as 42% of PBLS were gammadelta-T-cells expressing cytotoxic T-cell/Natural killer cell antigens, suggestive of a large granular lymphoproliferative disorder. Failure to recognize that these are normal gammadelta-T-cells could lead to the erroneous diagnosis of peripheral blood involvement with a T-cell neoplasm, especially in the setting of a history of non-Hodgkin's lymphoma. Cytometry (Comm. Clin. Cytometry) 38:280-285, 1999. Published 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10589043

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  8 in total

1.  Prolonged (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-driven antimicrobial and cytotoxic responses of pulmonary and systemic Vgamma2Vdelta2 T cells in macaques.

Authors:  Zahida Ali; Lingyun Shao; Lisa Halliday; Armin Reichenberg; Martin Hintz; Hassan Jomaa; Zheng W Chen
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

2.  Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR.

Authors:  Huiyong Wei; Dan Huang; Xiaomin Lai; Meiling Chen; Weihua Zhong; Richard Wang; Zheng W Chen
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  Gammadelta T cell immune manipulation during chronic phase of simian-human immunodeficiency virus infection [corrected] confers immunological benefits.

Authors:  Zahida Ali; Lin Yan; Nicholas Plagman; Armin Reichenberg; Martin Hintz; Hassan Jomaa; Francois Villinger; Zheng W Chen
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

4.  Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.

Authors:  Liuyan Jiang; Andrea D Abati; Wyndham Wilson; Maryalice Stetler-Stevenson; Constance Yuan
Journal:  Int J Clin Exp Pathol       Date:  2009-10-15

5.  The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells.

Authors:  Andrew Sandstrom; Cassie-Marie Peigné; Alexandra Léger; James E Crooks; Fabienne Konczak; Marie-Claude Gesnel; Richard Breathnach; Marc Bonneville; Emmanuel Scotet; Erin J Adams
Journal:  Immunity       Date:  2014-04-03       Impact factor: 31.745

6.  Phosphoantigen Burst upon Plasmodium falciparum Schizont Rupture Can Distantly Activate Vγ9Vδ2 T Cells.

Authors:  Marianne Guenot; Séverine Loizon; Jennifer Howard; Giulia Costa; David A Baker; Shaneel Y Mohabeer; Marita Troye-Blomberg; Jean-François Moreau; Julie Déchanet-Merville; Odile Mercereau-Puijalon; Maria Mamani-Matsuda; Charlotte Behr
Journal:  Infect Immun       Date:  2015-07-13       Impact factor: 3.441

7.  Prediction of Disordered Regions and Their Roles in the Anti-Pathogenic and Immunomodulatory Functions of Butyrophilins.

Authors:  Elrashdy M Redwan; Ahmed M Al-Hejin; Hussein A Almehdar; Abdelrahman M Elsaway; Vladimir N Uversky
Journal:  Molecules       Date:  2018-02-04       Impact factor: 4.411

8.  Human Peripheral Blood Gamma Delta T Cells: Report on a Series of Healthy Caucasian Portuguese Adults and Comprehensive Review of the Literature.

Authors:  Sónia Fonseca; Vanessa Pereira; Catarina Lau; Maria Dos Anjos Teixeira; Marika Bini-Antunes; Margarida Lima
Journal:  Cells       Date:  2020-03-16       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.